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Abstract
Background: Modeling of transmembrane domains (TMDs) requires correct prediction of interfacial residues for in-
silico modeling and membrane insertion studies. This implies the defining of a target sequence long enough to
contain interfacial residues. However, too long sequences induce artifactual polymorphism: within tested modeling
methods, the longer the target sequence, the more variable the secondary structure, as though the procedure
were stopped before the end of the calculation (which may in fact be unreachable). Moreover, delimitation of
these TMDs can produce variable results with sequence based two-dimensional prediction methods, especially for
sequences showing polymorphism. To solve this problem, we developed a new modeling procedure using the
PepLook method. We scanned the sequences by modeling peptides from the target sequence with a window of
19 residues.
Results: Using sequences whose NMR-structures are already known (GpA, EphA1 and Erb2-HER2), we first
determined that the hydrophobic to hydrophilic accessible surface area ratio (ASAr) was the best criterion for
delimiting the TMD sequence. The length of the helical structure and the Impala method further supported the
determination of the TMD limits. This method was applied to the IL-2Rb and IL-2Rg TMD sequences of Homo
sapiens, Rattus norvegicus, Mus musculus and Bos taurus.
Conclusions: We succeeded in reducing the variation in the TMD limits to only 2 residues and in gaining
structural information.
Background
IL-2 and IL-15 are two structurally close hematopoietic
cytokines, both presenting a functional redundancy and
both involved in immunology and inflammatory dis-
eases. IL-2 was implicated in the first metastatic mela-
noma immunotherapy [1] and is used in adoptive
immunotherapy with tumor infiltrating lymphocytes
(TILs). Most treatments require high doses of IL-2 [2,3]
a n di n d u c eas y s t e m i ct o x i c i t ys i m i l a rt oG M - C S F
(Granulocyte Macrophage-Colony Stimulating Factor)
treatments [4]. These secondary effects restrict the
therapy and have led to investigations into other forms
of treatment, such as the promising IL-15 therapy.
Transduction receptor chains IL-2Rb and IL-2Rgc
(class I hematopoietic receptors) form an intermediate-
affinity complex capable of binding IL-2 and IL-15.
Whereas the IL-2Rb chain is restricted to dimeric recep-
tor for IL-15 and IL-2 [5] or to specific trimeric recep-
tors (IL-2Rb/IL-2Rg/IL-2Ra and IL-2Rb/IL-2Rg/IL-
15Ra), the IL-2Rgc chain is involved in gc-family recep-
tors, that is to say the IL-2, IL-4, IL-7, IL-9, IL-15, IL-21
and GM-CSF receptors[6]. gc-deficit is implicated in
immunodeficiency, such as X-linked Severe Combined
ImmunoDeficiency (X-SCID)[7].
Fluorescence resonance energy transfer (FRET) studies
suggest that IL-2Ra, IL-7Ra and IL-15Ra chains are co-
localized[8] with IL-2Rb and gc chains within lipid rafts
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any medium, provided the original work is properly cited.[9]. IL-2Ra and IL-15Ra chains also appear to co-loca-
lize in lipid rafts with MHC (I and II) chains, with
ICAM-1 in antigen-presenting cells (APC), and with
lymphoma and CD4+ T-cells[10,11]. The majority of
these chains are involved in the immune synapse (IS)
[10-12] and this supports the implication of IL-2/IL-15
receptors in this IS complex, contributing to their very
fast response to stimuli.
Due to the therapeutic interest of IL-2 and IL-15 and
their activating properties on the IL-2Rb/IL-2Rg recep-
tor, we aimed to study the two chains forming this
receptor. However, the structure of these chains remains
unknown due to the crystallization problems of trans-
membrane domains (TMDs).
Since no structural models of IL-2Rb and gcT M D s
are available, we needed to model them. We first tried
to predict the TMDs using sequences as input via 2D
TMD-determination methods (evaluated according to
Punta[14] and Zhou[15]) but this led to fluctuations in
predicting interfacial residues, according to the species
or the method (Figure 1). In the same way, long
sequences in 3D structure predicting methods led here
to highly flexible TMD models (with a root mean square
deviation (RMSD) of between 5 and 19 Å), especially for
IL-2Rb. To resolve this problem, we developed a proce-
dure to define the TMD center by scanning the
sequence in different species. This procedure uses the
in-silico PepLook method[16,17] combined with the
Impala method for predicting the membrane restraint
effect on the structure.
We validated our approach with sequences of proteins
with known TMD structures (GpA, EphA1 and Erb2)
and succeeded in correctly predicting the TMD limits.
We then applied this approach to the IL-2Rb and IL-
2Rg sequences. Structures of both TMDs were helical,
and residues responsible for flexibility or interaction
were determined.
Results
As we were looking for structural and functional data
on IL-2Rb and IL-2RgcT M D s ,w ef i r s ta n a l y z e dt h e
available sequences among different species.
Multi-species alignment of sequences and
transmembrane segment prediction
According to inter-species alignment of IL-2Rb
sequences (Figure 1), identity is low and only two gly-
cines (G253 and G256) around the TMD center are
strictly conserved, separated by 2 or 3 a.a., correspond-
ing to either a GxxG (GG3) pattern (for anthropoids
and the duck-billed platypus) or a GxxxG (GG4) pattern
(for other non-anthropoids). We can observe that the
GG3 motif corresponds to a flip of G{CS} in the GG4
pattern, observed in cows, rats and mice, to {CST}G.
The horse sequence shows a glycine insertion just
before the GG3 pattern. Sequence alignments show con-
servation of some charged and polar residues at the
extremities of the potential TMD.
The shared IL-2Rgc chain is much more conserved
than IL-2Rb for mammals with an identity higher than
70%. A pattern can be identified: F258AxEAVxIxxGxM-
GLIxxLxxVYxWLER285-box1 with a potential GG3 pat-
tern and where box1 represents the cytosolic motif
involved in interaction with the second messenger JAK-
kinase. Although this chain is shared by 7 different
receptors and its sequence would therefore be expected
to be conserved, we were very surprised to observe a
proline to serine substitution just before the
v267GsMGLI273 conserved region, in pigs, cows, rats,
mice and dogs, which could induce a kink.
S i n c ew ew a n t e dt om o d e lt h ec h a i n sf o rm o d e l i n g
and interaction studies, the first step was to accurately
delimit the TMD: we tested TMD predictions for IL-
2Rb and IL-2Rgc sequences in different species using
the Split4, TMHMM2, THUMBU, Sosui, HMMTOP
and Memsat3 methods[14,15]. 2D-structure prediction
methods confirmed that the TMDs of IL-2Rb and IL-
2Rgc are helical, polytopic and mono-spanning. How-
ever, TMD predictions differed with a maximal shift of
8 residues, depending on the species and on the predic-
tion method (Figure 1).
In a first approach, we modeled the whole predicted
TMD, composed of 27 a.a. for IL-2Rb (W243-N269)
and 26 a.a. for IL-2Rgc (A259-E284), using PepLook
[16,17], in a hydrophobic environment or with Impala
membrane restraints. PepLook allows the prediction of
the 3D structure and flexibility using the sequence only
as input. IL-2Rb showed no consensus because of the
high structural flexibility of the I258-N269 segment
models (with a RMSD for the 99 best structures of
between 5 and 19 Å; data not shown). IL-2Rb was
assumed to be contained inside the membrane but it
cannot be inserted into the membrane using the Impala
method[18]. IL-2Rgc presents a much reduced flexibility.
We noticed that polymorphism seemed to be sequence-
length dependent (over 25 residues) for sequences pre-
senting high flexibility such as IL-2Rb.
Calibration of the in-silico TMD-determination method
We carried out a local prediction by scanning the pep-
tide sequence in a hydrophobic environment with a slid-
ing window, so as to delimit more precisely the TMD
limits and flexible domains (Figure 2-A). In order to
determine the window length avoiding polymorphism
induced by sequence length, we used the TMD
sequences from proteins presenting NMR structures
with a low RMSD (for the different models from one
protein) of between 0.22 and 0.5 Å, with different
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Page 2 of 13Figure 1 Inter-species alignment of IL-2R chains and prediction of TMD. Sequences from different species (gi accession numbers are given)
were aligned for the region around the suspected TMD region in IL-2Rb (left) and in IL-2Rg (right). Percentages represent the identity of
sequences compared to the human sequence of the aligned region (sequence differences in comparison with humans are indicated in bold).
The consensus sequence is given: conserved amino acids (a.a.) are indicated by the letter corresponding to these residues. Complete sequences
were submitted to TMHMM2 and Sosui web-servers to predict TMD regions: the a.a. included in the TMD according to the TMHMM2 prediction
are indicated by an orange background, and Sosui predictions by boxes. In the second part of the figure, boxes show TMD predictions for the
Homo sapiens sequence with different methods: TMHMM2, split4, THUMBU, Sosui, HMMTOP and memsat3. The line “Homo in Impala” shows
results from this study: the TMD center (in bold), the predicted interfaces (with orange background) and the juxta-membrane domains (with
blue background).
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Page 3 of 13lengths: we used Gpa (pdb: 1afo), EphA1 (2k1k) and
Erb2 (2jwa). We then decided to choose the window
length inducing a flexibility of less than the double
RMSD observed in NMR models: for this, we deter-
mined the window length where the 99 best energetic
structures, resulting from the PepLook method, were
clustered with a RMSD lower than 1 Å. We found that
the window length was lower than or equal to 19 a.a.
In order to calibrate the strategy, we applied it to Gpa,
EphA1 and Erb2, whose NMR structures and TMD cen-
tral residues are known as a result of using the Impala
method[18,19] and/or OPM database models[20]. We
Figure 2 Illustration of the method applied to the GpA sequence. (A) Scan of peptides with a window of 19 a.a. length, each line
represents a PepLook run and its 99 structures. (B) Scan-peptides were submitted to the Impala method for membrane insertion prediction. (C)
Statistical analysis showing for each residue the average of the percentage of helical structure (%), of the ASAr and of the membrane insertion
(distance to the membrane in Å). These data were used to determine TMD residue at the center of the membrane.
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Page 4 of 13analyzed different parameters for all the peptides gener-
ated by the sliding window procedure: the mean of the
helical structure with a window of 19 residues, the
hydrophobic to hydrophilic accessible surface ratio
(ASAr), the average mean force potential (MFP) percen-
tage and the depth of membrane insertion with Impala.
This means that for each residue, we analyzed 11 scans,
generating 1089 structures encompassing the residue of
interest. Of all these parameters tested with sequences
from known NMR-structures, we found that the best
criterion for defining the TMD center was the ASAr
mean with the highest value (close to 5) for the central
residue compared to a value of around 2 for interfacial
amino acids. This was confirmed by the mean of the
helical structure, which must be up to 75%. The Impala
method also confirmed these central residues, except
for Erb2, for which we observed a shift of 3 residues
(Figure 3-C).
Structural prediction of the IL-2Rb TMD
Following these results, we submitted the IL-2Rb
sequence from 4 different species (Homo sapiens, Rattus
norvegicus, Mus musculus and Bos taurus) to this proce-
dure. The four species have a similar helical structure,
ASAr and membrane penetration (Figure 4-ABC): ASAr
and the Impala scan allowed us to predict that the
TMD is centered on F255 and G256, which is consistent
with the percentage of helical structure at these posi-
tions (close to 80%). However, in Homo sapiens,t w o
close maxima were observed for insertion and ASAr
(see blue stars in Figure 4-B &4C). The W243 residue of
IL-2Rb seemed to be localized at the extracellular mem-
brane interface and Y262 on the intracellular side,
which is consistent with known data regarding TMDs
[21]. The scan-peptides presenting the highest RMSD
were centered on residues from L260 to L264 (more
than 1 Å as against less than 0.1Å for other peptides).
Structural prediction of the IL-2Rgc TMD
The same procedure was applied to IL-2Rg sequences:
the predicted TMD is centered on G271 and L272 for
humans and on homologous residues for other species.
Despite an identical result for ASAr in all species,
human structures presented a shift of two residues in
the Impala scan (centered on S269, M270 and G271).
This chain structure is less flexible than for IL-2Rb but
peptides centered on residues from F281 to L283 pre-
sented a RMSD higher than 0.8Å.
MFP analysis
The MFP percentage[22] allows us to predict whether a
residue is in a stable structural environment (value
higher than 60%) or not (lower than 40%). The struc-
tures obtained with our scan method were used to
calculate MFP values. Concerning IL-2Rb, the flexible
I258-N269 segment presented an MFP percentage of
lower than 40%: such values mean that residues are not
stabilized and would therefore need to interact. I241
and Y262 and I265 interfacial residues presented MFP
percentages of lower than 30% and, in the center of the
TMD, F255 and F257 also had low MFP percentages
(Figure 5). For IL-2Rg, cytoplasmic residues of TMD
extremities presented low MFP values as for IL-2Rb
(less than 40%) but for fewer residues: L272-I274 and
C278-W282. The interfacial residue N254 presented an
extremely low MFP percentage with only 14%.
Discussion
Efficiency of the local scan with the PepLook procedure
The absence of 3D structures for IL-2Rb and IL-2Rg led
us to model them in-silico. Calculation time for such
modeling simulations increases with the number of resi-
dues and with the use of supplementary restraints.
We first modeled the whole potential TMD, but this
led to a long calculation time and structural flexibility at
both membrane interfaces with artifactual loops going
back into the membrane; moreover, we found that poly-
morphism increased with sequence length. Results of
sequence-based TMD 2D-predictions did not allow us
to delimit TMDs accurately or to reduce the target
sequence. In addition, we found no improvement with
these 2D-predictions for our target proteins as com-
pared to the use of more basic methods, which include
analyzing the hydrophobicity scale or the most fre-
quently present residues at the membrane interface
(Trp>Phe>Tyr>Leu>Iso>Cys) or the charged residues
usually present at the juxta-membrane interface (Glu
and Asp at extracellular side, and Lys and Arg at the
cytosolic side), as reviewed by White[21] and Popot[23].
In this paper, we developed an in silico method (Fig-
ure 2-A) consisting of a local scan with a 19 a.a. window
using the PepLook method, in order to delimit the TMD
more accurately. This scan also allows us to predict
other structural properties such as structural poly-
morphism and potential interaction residues.
We calibrated our method by delimiting precisely
intra-membrane regions of mono-spanning receptors
using proteins whose NMR structures are known and
whose central residues are determined: GpA, EphA1
and Erb2. We analyzed different parameters for all the
peptides generated: the helical structure, the ASAr, the
average MFP percentage and the depth of membrane
insertion with Impala. The best criterion for defining
the TMD center was found to be ASAr, which pre-
sented the highest value for the central residues. The
percentage of helical structure and membrane insertion
with the Impala method provided complementary data
to support this result. However, the Impala parameter
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Page 5 of 13Figure 3 Determination of the potential TMD center of NMR-structures in the membrane. According to the statistical results from the
PepLook scan runs for GpA (A), EphA1 (B) and Erb2 (C), we show the average percentage of helical structure in all the structures obtained with
a window of 19 a.a. (red line). The blue line represents the average of the ratio of hydrophobic to the hydrophilic accessible surface (ASAr) for
19 a.a. long peptides with a window of 5. The orange line represents the depth of the average penetration into the membrane from 10 to -10 Å
of the 19 a.a. long peptides with a window of 3. The amino acid on the × axis represents the center of the considered scan-peptides. TMD
centers, determined by the Impala[18] and OPM methods[20] with NMR structures, are indicated by a box for each monomer considered.
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Page 6 of 13Figure 4 Determination of the potential TMD center of IL-2Rb and IL-2Rg in the membrane. According to the statistical results from the
PepLook scan run for the IL-2Rb (4) and the IL-2Rg (5), (A) the average percentage of helical structure in all the structures obtained with a
window of 19 a.a. is shown for the different species as follows: Homo sapiens (blue), Bos taurus (purple), Mus musculus (dark purple), and Rattus
norvegicus (dark red). The amino acid on the × axis represents the center of the considered scan-peptides, according to the species considered.
The inter-species mean is shown in red and the acceptable TMD limits are represented by a dashed line at 75%. (B) The average ASArs are
shown for the 4 species with a window of 5 amino acids; the inter-species mean is shown in blue. (C) We show the average depth of the
penetration of the 19 a.a. long peptides, with a window of 3, in the membrane from 10 to -10 Å for the 4 species, and the inter-species mean
(orange). (D) The means of each parameter are shown in the same graph, and the deducible TMD center is indicated by a dashed arrow. (*)
Blue stars show the single variations described for Homo sapiens.
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Page 7 of 13of scanned-peptides showed different results in the case
of Erb2.
In order to understand this phenomenon, we split the
reference structure of GpA into small peptides from 22
to 33 residues and submitted them to the Impala mem-
brane insertion method: the orientation and the penetra-
tion of the peptide into the membrane were very
variable for small peptides, even for a shift of only one
residue (See additional file 1). We also noticed that
charged residues were not always sufficient to explain
this. So we attribute the different results in determining
the central residue of Erb2 to the importance of the
residues at the end of the peptides for membrane
insertion.
Moreover, the above procedure could be very useful
for determining minimal protein sequences that could
be used in experimental structure determination meth-
ods in a hydrophobic environment. Our results show
that adding or removing only one residue at the end of
the peptide can totally change its orientation and/or
penetration into a lipid environment. However, it does
not seem possible to establish a simple rule on this. So
if peptides cannot penetrate into a lipid environment,
stabilization induced by lipid interaction cannot occur
during experimental structure determination methods.
Evolution of sequences and structures of the IL-2Rgc and
IL-2Rb chain receptors
As we obtained good results for known TMD structures,
we used the same method to determine the TMDs of
the different sequences of IL-2Rb and IL-2Rgc for Homo
sapiens, Bos taurus, Mus musculus and Rattus
norvegicus.
The IL-2Rgc chain sequence was much more conserved
than for IL-2Rb: this can be explained by the fact that IL-
2Rgci ss h a r e db yt h eI L - 2R e c e p t o r( I L - 2 R b/IL-2Rg)a n d
by the IL-4, IL-7, IL-9, IL-15a n dI L - 2 1r e c e p t o r s .T h e
conserved region of IL-2Rgc( v 2 6 7 GsMGLI273) contains
a GG3 pattern, which is important for dimerization and
may be involved in the recruitment of other receptor
chains. Unexpectedly, mice, rat, dog, cow and pig
sequences presented a proline just before this conserved
region. This proline is involved in a kink on the extracel-
lular side of the TMD helix, contrary to the case of
anthropoids and the duck-billed platypus.
TMD predictions should be equivalent, since the
sequence alignments present conservation of some
charged, polar and interfacial residues near the puta-
tive TMD. The four species showed similar results
(Figures 4 &6) and this similarity allowed us to use
inter-species means of each different parameter to
avoid isolated ambiguous values: the residue presenting
the highest ASAr or best Impala insertion values for
Homo sapiens was characterized by a double maximum
(see blue stars in Figure 4-B &4C). The first result was
not correct according to the charged residues, which
were then inside the membrane. Using results across
species showed a better correlation (Figure 6-B). More-
over, ASA values were more precise here than values
from 2D methods (because we calculated them on 3D-
structures and not with average values) and we found
Impala to be a good complementary parameter where
Figure 5 Determination of the MFP percentage for IL-2Rb and IL-2Rg scanned sequences. After modeling the scan-peptides corresponding
to the sequence of both proteins, means of the MFP percentages across the sequence were calculated and are shown (IL-2Rb in red and IL-2Rg
in blue).
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Page 8 of 13Figure 6 Determination of the potential TMD center of IL-2Rb and IL-2Rg in the membrane. According to the statistical results from the
PepLook scan run for the IL-2Rb (4) and the IL-2Rg (5), (A) the average percentage of helical structure in all the structures obtained with a
window of 19 a.a. is shown for the different species as follows: Homo sapiens (blue), Bos taurus (purple), Mus musculus (dark purple), and Rattus
norvegicus (dark red). The amino acid on the × axis represents the center of the considered scan-peptides, according to the species considered.
The inter-species mean is shown in red and the acceptable TMD limits are represented by a dashed line at 75%. (B) The average ASArs are
shown for the 4 species with a window of 5 amino acids; the inter-species mean is shown in blue. (C) We show the average depth of the
penetration of the 19 a.a. long peptides, with a window of 3, in the membrane from 10 to -10 Å for the 4 species, and the inter-species mean
(orange). (D) The means of each parameter are shown in the same graph, and the deducible TMD center is indicated by a dashed arrow. (*)
Blue stars show the single variations described for Homo sapiens.
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Page 9 of 13two close maxima were observed, as in the hIL-2Rb
case.
Finally, we found that the TMDs of IL-2Rb and IL-
2Rg were respectively centered between F255-G256 and
G271-L272. The delimitation of the TMD depends on
the tilt angle, which was lower than 30°, so TMDs with
interfaces are to be limited to W243-C267 for IL-2Rb
and F258-L283 for IL-2Rg.
Another advantage of this method is the possibility of
calculating MFP percentage levels [22]: our results showed
that these were lower than 40% for the I258-N269 seg-
ment from IL-2Rb, in contrast to the remainder of the
sequence; so this domain needs interactions with another
molecule to stabilize its structure. According to this MFP
analysis, I241 Y262 and I265 residues from IL-2Rb could
therefore interact in particular with lipids or proteins
which could stabilize the structure of the chain receptors.
Similar results were found for IL-2Rg: residues in L272-
I274 and in C278-W282 presented MFP percentages of
between 40 and 30% and may interact with the cytoplas-
mic part of IL-2Rb and/or lipids. The interfacial residue
N254 presented a very low MFP percentage (14%) and
may be important for interaction.
The extremities of the IL-2Rb and IL-2Rg TMDs pre-
sent a very high level of conservation and may be
involved in a stable orientation in every species. These
residues are implicated in interactions with lipids or in
the recruitment of several chains known to be co-loca-
lized with IL-2Rgc: IL-2Rb,I L - 2 R a,I L - 1 5 R a and IL-7Ra
[8-24]. In addition, Constantinescu[25] has described an
essential hydrophobic motif for EPO-R activity, at the
juxta-membrane side, with conserved hydrophobic resi-
dues in many cytokine receptors located in front of func-
tional domains (such as box-1). Homologs of this
interfacial motif are found in both cytoplasmic sides of
TMDs, presenting a low MFP, and may modulate protein
orientation: LxxxFW for IL-2Rg and LxxxLI for IL-2Rb.
Conclusions
In conclusion, our scan-based method is more accurate
than 2D methods for the delimitation of TMDs, espe-
cially for polymorphic domains or across different spe-
cies. We validated our approach with structures whose
NMR-structures are known and applied it to IL-2Rb
and IL-2Rgc. These scans also allowed us to obtain
more information about the structure and polymorph-
ism of TMDs, about MFP and potential interactions,
and about residues that are important in membrane
insertion. A webserver for this Peplook-based method
was developed during this study and a Peplook webser-
ver will be accessible in a few months at http://www.
fsagx.ac.be/bp.
The method described in this paper is currently being
developed to model longer target sequences of 34
residues. Preliminary results correlate our predictions of
TMD limits with the Impala method and suggest that
polymorphism is also better identified for those
sequences in a rational calculation time. Moreover, this
method will describe how already folded stable domains
can be involved in the folding of flexible domains, such
as the domain of IL-2Rb.
Methods
Sequence and inter-species alignments
We used reference sequences for both proteins, IL-2Rb
(Homo sapiens gi:4504665, Pan troglodytes gi:78486576,
Macaca mulatta gi:109094076, Canis familiaris
gi:73969771, Bos Taurus gi:119894052, Rattus norvegicus
gi:6981098, Mus musculus gi:6680427, Equus caballus
gi:149743257 and Ornythoryncus a. gi:149430125) and
IL-2Rgc( Homo s. gi:4557882, Pan t. gi:114689013,
Macaca m. gi:78486582, Canis f. gi:50978962, Bos t.
gi:27819628, Rattus n. gi: 61097900, Mus m. gi:7305181,
Callithris j. gi:146199402 and Sus scrofa gi:148747300).
Sequences were aligned for each protein using Clustal-
W http://www.ncbi.nlm.nih.gov/tools/cobalt and we
modeled proteins from each species whose IL-2Rb and
IL-2Rg sequences were both available.
TMD delimitation using 2D methods
We used 2D-methods evaluated by Punta[14] and Zhou
[15]: TMHMM2 http://www.cbs.dtu.dk/services/
TMHMM, split4 http://split.pmfst.hr/split/4/, THUMBU
http://www.smbs.buffalo.edu/phys_bio/Softwares-Servi-
ces_files/thumbup.htm, Sosui http://bp.nuap.nagoya-u.
ac.jp/sosui/, HMMTOP http://www.enzim.hu/hmmtop/
html/submit.html and memsat3 http://bioinf.cs.ucl.ac.
uk/psipred/.
The PepLook procedure[16]
The PepLook method uses a de novo search for energy
minima through an iterative in silico Boltzman-sto-
chastic procedure. For each sequence, PepLook gener-
ates 1 to 5 million structures: each structure is
randomly created by attributing to each amino acid
f r o mt h es e q u e n c e ,ac o u p l ea m o n gt h es e to f6 4p h i /
psi couples, described by Etchebest[26] as being suffi-
cient to describe almost all protein structures in the
protein databank (PDB). The energy of the structures
is calculated using force fields as described below and
ranked for the 104 structures randomly created during
a step. At the end of each step, probabilities for each
of the 64 phi/psi couples are modulated according to
the energy of the structure: the probability of the first
100 phi/psi couples only found in the energetically
favorable structures are increased for the next step,
and the probability of the first 100 couples, associated
only with energetically unfavorable structures, is
Charlois et al. BMC Structural Biology 2011, 11:26
http://www.biomedcentral.com/1472-6807/11/26
Page 10 of 13decreased. The stabilization of probabilities occurs
after a number of steps equal to the sequence length
multiplied by 10. During the procedure, structures
with the lowest energy are retained so as to obtain the
99 best models at the end of the procedure; the prime
model is the best structure among the 99.
The 99 structures are clustered according to a RMSD
(root mean square deviation) for all atoms below 1 Å.
In order to run the PepLook procedure in the membrane
environment, the Impala restraints are added to the
total energy (see below).
The PepLook scan followed by the Impala method (Figure
2)
We scanned target sequences using the PepLook proce-
dure[16,17] in a hydrophobic environment with a win-
d o wo f1 9a m i n oa c i d sa n das h i f to fo n ea m i n oa c i d
(Figure 2A). This window length was selected to be the
largest with the best peptide stability, that is to say the
lowest number of clusters and the maximum number of
structures by cluster (see results). With these scanned
peptides, we performed a statistical analysis for each
residue, by excluding the 4 amino acids at each extre-
mity of the scanned peptides, and calculating the aver-
age of 3 parameters (Figure 2A): we analyzed the
structure, the ratio of hydrophobic to hydrophilic acces-
sible surface area (ASAr), and the insertion into an
implicit membrane:
The Pex definition[27,28] was used to establish the
secondary structure of residues, according to the phi/psi
dihedral angles: helical conformation was attributed
when the phi/psi dihedral angles couple was in a circle
of 80° around the point (phi = 57°; psi = 47°) of the
ramachadran plot, and when the distance between (N-)
Hi from the backbone of residue i and either the back-
bone (C=)Oi+4 for the alpha helix, or the backbone
(C=)Oi+3 for the 3-10 helix, was lower than 0.3 nm.
Beta-sheet conformation of the residue was considered
when the phi/psi couple was in a circle of 90° around
the point (phi = -129°; psi = 123°) of the Ramachadran
plot. In other cases, residues were considered as random
coiled.
Hydrophobic and hydrophilic accessible surface areas
[29], calculated using 3D-structures via PepLook, allowed
us to determine the average ASAr for each residue.
Each scanned peptide was then submitted to Impala
(Figure 2B) in the membrane core between 10Å and
-10Å (because of the length of peptide): we calculated
the mean of the best z coordinate for each of the 99
structures of a scan from the same window. The best z
penetrating value for each central a.a. of peptides was
determined with a window of 7 scanned peptides.
We considered that the central residue in the mem-
b r a n ef r o mt h es c a n n e ds e q u e n c ew a st h er e s i d u ew i t h
the highest ASAr and the highest membrane penetration
(minimal z). We also verified that the secondary struc-
ture for the domain of 18 residues centered on this
amino acid was helical, in order to allow its membrane
localization.
PepLook energy field calculations
PepLook calculates the energy of peptides through an all
atom description of structures using the following
energy terms:
London - van der Waals energy describes the energy
of interaction between unbound atoms, and its contribu-
tion was calculated here using the 6-12 Lenard-Jones
potential:
Evdwij = −A/dij6 +B /dij12
where dij is the distance between atoms i and j, and A
and B are coefficients assigned to atom pairs.
The energy of electrostatic interactions between
unbound charged atoms was given by Coulomb’se q u a -
tion:
Eelecij = qiqj/(epsilon(z) · dij
where dij is the distance between atoms i and j, qi and
qj are the respective fractions of unit charges (using
FCPAC partial atomic charges[30]). Epsilon(z) is the
dielectric constant of the medium whose variation, with
t h ed i s t a n c ezf r o mt h em e m b r a n ec e n t e r ,a n dt h i sw a s
simulated here between 0.2 and 1 nm by a sigmoid var-
iation (of factor 1) from 1 to 80 C².J-1.m-1, as described
by Smith[31].
Intramolecular hydrophobicity energy decreases expo-
nentially with the distance between atoms and was eval-
uated by the following equation:
Epho intraij = deltaij · (Etri · ﬁj + Etrj · ﬁj) · exp(r0i+r 0j − dij/2rsol)
where deltaij is equal to -1 if the atoms are both
hydrophobic or both hydrophilic, and +1 otherwise; Etri
and Etrj are the transfer energy for these atoms (cate-
gorized according to seven atomic types[32]) from a
hydrophobic phase to a hydrophilic one; fij is the surface
ratio of atom i covered by atom j, and fji the surface
ratio of atom j covered by atom i; r
0ii st h ev a nd e r
Waals radius of atom i; dij the distance between atoms i
and j; rsol is the radius of a water molecule[33].
The solvent contribution in a hydrophilic environment
was calculated implicitly by the external hydrophobicity
for each atom:
Epho outi = Si · Etri
where Etri is the transfer energy and Si is the solvent
accessible surface of atom i calculated with a surface
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Shrake and Rupley[34].
In a membrane environment, we used the Impala
method and this solvent contribution was replaced by
the empirical equation describing the membrane poten-
tial energy (see below).
Impala energy fields[18]
The DPPC membrane was implicitly described by an
interface function C(z), described previously: in a
bilayer, C varies along the normal to the bilayer surface,
the z-axis, where z = 0 at the center of the membrane:
C(z) =1 / (1 + exp((|z|−z0) · alpha))
where z0 and alpha are determined so that C(z) is
equal to 1 if |z| > 1.8 nm, and equal to 0 if |z| < 1.35
nm, as tested for peptide insertion into a bilayer[18].
The interaction of proteins with the membrane was
described by the membrane potential energy corre-
sponding to the sum of the membranous hydrophobicity
energy (corresponding also to the interface restraint)
and of the membrane lipid perturbation due to the pep-
tide insertion:
Epot memi = 2Epho memi + Elip memi
Where:
Epho memi = −Si · Etri · C(zi)
where Si is the accessible surface of atom i to solvent,
calculated using the method of Shrake and Rupley[34],
Etri is the transfer energy by unit of accessible surface
area (defined for seven atomic types) for atom i, and zi
the position on the z-axis of the projection of the center
from atom i. This equation for Epho_mem is the oppo-
site of the Delta-Gtransfer used by the OPM method
[20] where alpha = 1/0.9Å-1.
Elip memi = alip · Si · C(zi)
where alip is an empirical constant (fixed to 0.018),
which tends to increase if interactions are not as favor-
able as lipid/lipid interactions.
The Impala method consists of moving the protein
across the z axis orthogonal to the implicit membrane
surface with a constant step (here, 0.01 nm). At each
step, the energy is calculated for different orientations of
the peptide (here, 10000 steps and a maximum orienta-
tion of 360°). The best z position and the best insertion
angle correspond to the position with the lowest
Epot_mem.
Mean Force Potential (MFP)
The 494 structures optimized by the Richardson group[35]
were used by our laboratory to calibrate an energy
function and define the mean MFP by residue. This allows
the calculation for each residue of the percentage of the
mean MFP defined for this residue[22]: the higher the
MFP percentage, the closer the atomic environment of the
considered residue to the stable atomic environment
found in PDB reference structures. Inversely, a low MFP
percentage means that the atomic environment is not
complete and that atomic energy loss needs to be counter-
balanced either by secondary structure stabilization, or by
an inter-molecular interaction inducing structural
stabilization.
Calculations were made using a quadri-core PC at Hz
and 4 Go of RAM.
Additional material
Additional file 1: Insertion into the membrane of peptides
corresponding to the splitting of GpA NMR-structures. The Gpa NMR
structures (1afo) were split into peptides of different length and inserted
into an implicit membrane using the Impala method: the histogram
shows the tilt angle toward the normal to the membrane for inserted
peptides, and lozenges correspond to the distance from the center of
the membrane.
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